Clinical record
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Creagan ET, Oertel CG, O’Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979; 301: 687-690.
- 2. Xue CC, Zhang AL, Lin V, et al. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med 2007; 13: 643-650.
- 3. G6PD Deficiency Favism Association. G6PD deficit — drugs that should be avoided: official list. Associazione Italiana Favismo; 1996–2018. https://www.g6pd.org/en/G6PDDeficiency/SafeUnsafe/DaEvitare_ISS-it (viewed Aug 2017).
- 4. Huang YC, Chang TK, Fu YC, Jan SL. C for colored urine: acute hemolysis induced by high-dose ascorbic acid. Clin Toxicol (Phila) 2014; 52: 984.
- 5. Rees DC, Kelsey H, Richards JD. Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. BMJ 1993; 306: 841-842.
- 6. Campbell GD, Steinberg MH, Bower JD. Letter: ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med 1975; 82: 810.
- 7. Mehta JB, Singhal SB, Mehta BC. Ascorbic-acid-induced haemolysis in G-6-PD deficiency. Lancet 1990; 336: 944.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.